ArticleJournal of Ayurveda and integrative medicine
A critical analysis of CTRI registered AYUSH studies for COVID- 19.
Article in Journal of Ayurveda and integrative medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Trial
- A Systematic Analysis of COVID-19 Clinical Trials Registered in the Clinical Trials Registry of India.Cureus · 2024Article
- Characteristics and result reporting of registered COVID-19 clinical trials of Chinese and Indian traditional medicine: A comparative analysis.Frontiers in medicine · 2023Article
- Mechanistic insights from the review and evaluation of ayurvedic herbal medicines for the prevention and management of COVID-19 patients.Journal of herbal medicine · 2022Article
- Article
- A methodological analysis of CTRI registered clinical trials on ayurveda interventions for COVID-19 management.Journal of Ayurveda and integrative medicineArticle
- Can Guduchi (Tinospora cordifolia), a well-known ayurvedic hepato-protectant cause liver damage?Journal of Ayurveda and integrative medicineReview
- Research status of traditional & complementary medicine systems across the world.Journal of Ayurveda and integrative medicineArticle
- India in COVID-19 times: Modern and wiser.Journal of Ayurveda and integrative medicineArticle
- Ayurvedic Response to COVID-19 Pandemic in Kerala, India and Its Impact on Quarantined Individuals - A Community Case Study.Frontiers in public healthArticle
- Ayurveda co-interventions have supported complete recovery in severe COVID-19 infection with a chest severity score 18/25: A case report.Journal of Ayurveda and integrative medicineArticle
- Dissemination of COVID-19 research: Time to walk the talk.Journal of Ayurveda and integrative medicineArticle
- Integrative management of critical case of Covid 19 withJournal of Ayurveda and integrative medicineArticle
- Impact of AYUSH interventions on COVID-19: a protocol for a living systematic review and meta-analysis.F1000ResearchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe COVID-19 pandemic has provided an opportune time to evaluate the efficacy of traditional medicine. Many clinical studies involving AYUSH systems are being initiated and registered with Clinical Trials Registry - India (CTRI) since last few months.
objectiveThe present work is an analysis of different characteristics of these studies on the basis of available datasets. MATERIAL AND
methodsCOVID-19 related clinical studies involving the healthcare systems of AYUSH, registered on CTRI between 1
resultsA total of 197 AYUSH studies were registered on CTRI of which majority (n = 113) were from
conclusionOur analysis revealed some interesting characteristics of the registered studies such as use of platform trial design, system specific criteria for assessment and personalized interventions. Though it was not possible to evaluate the quality of these studies in view of the limited dataset used for trial registration, we could notice variations in important characteristics like sample size, treatment arms, comparator used and study duration according to the primary aim of the studies. Overall, the present review underlines the formidable efforts of AYUSH sector in combating COVID-19 outbreak.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.